Author: Somlor, Somphavanh; Brossault, Ludovic; Grandadam, Marc
                    Title: Evaluation of VIDAS(®) Diagnostic Assay Prototypes Detecting Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM and IgG Antibodies  Cord-id: mf3v7q8f  Document date: 2021_7_7
                    ID: mf3v7q8f
                    
                    Snippet: Dengue is a serious tropical disease caused by the mosquito-borne dengue virus (DENV). Performant, rapid, and easy-to-use assays are needed for the accurate diagnosis of acute DENV infection. We evaluated the performance of three prototype assays developed for the VIDAS(®) automated platform to detect dengue NS1 antigen and anti-dengue IgM and IgG antibodies. Positive and negative agreement with competitor enzyme-linked immunosorbent assays (ELISA) and rapid diagnostic tests (RDT) was evaluated
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Dengue is a serious tropical disease caused by the mosquito-borne dengue virus (DENV). Performant, rapid, and easy-to-use assays are needed for the accurate diagnosis of acute DENV infection. We evaluated the performance of three prototype assays developed for the VIDAS(®) automated platform to detect dengue NS1 antigen and anti-dengue IgM and IgG antibodies. Positive and negative agreement with competitor enzyme-linked immunosorbent assays (ELISA) and rapid diagnostic tests (RDT) was evaluated in 91 Lao patients (57 adults, 34 children) with acute DENV infection. The VIDAS(®) NS1 assay showed the best overall agreement (95.6%) with the competitor NS1 ELISA. Both VIDAS(®) NS1 and NS1 ELISA assays also demonstrated high sensitivity relative to DENV RNA RT-PCR set as gold standard (85.7% and 83.9%, respectively). In contrast, NS1 RDT was less sensitive relative to DENV RNA RT-PCR (72.7%). The overall agreement of VIDAS(®) IgM and IgG assays with the competitor assays was moderate (72.5% for IgM ELISA, 76.9% for IgG ELISA, and 68.7% for IgM and IgG RDT). In most analyses, test agreements of the VIDAS(®) assays were comparable in adults and children. Altogether, the VIDAS(®) dengue prototypes performed very well and appear to be suitable for routine detection of dengue NS1 antigen and anti-dengue IgM/IgG antibodies.
 
  Search related documents: 
                                Co phrase  search for related documents- accurate diagnosis and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
  - accurate diagnosis and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9
  - accurate diagnosis and low number: 1, 2, 3, 4, 5
  - accurate diagnosis and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
  - acute infection and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9
  - acute infection and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
  - acute phase and low number: 1, 2
  - acute phase and low sensitivity: 1, 2, 3, 4, 5, 6
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date